GNI Group Announces ¥44.8 Billion Acquisition of Ayumi Pharmaceutical
GNI Group Co., Ltd. has reached an agreement to fully acquire Ayumi Pharmaceutical. The transaction is valued at ¥44.8 billion, marking a significant move for GNI Group. This acquisition will integrate Ayumi Pharmaceutical into GNI's operations.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.